What is AbCellera Biologics Inc.'s financing cash flow?

AbCellera Biologics Inc. (ABCL) reported financing cash flow of $7.19M in Q1 2026.

How has AbCellera Biologics Inc.'s financing cash flow changed year-over-year?

AbCellera Biologics Inc.'s financing cash flow increased by 20.5% year-over-year, from $5.97M to $7.19M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

AbCellera Biologics Inc. ABCL Financing Cash Flow

Financing Cash Flow at other companies

Twist Bioscience CorporationTWST

$4.14M+29.5%

Recursion Pharmaceuticals, Inc.RXRX

-$3.47M-109%

AnaptysBio, Inc.ANAB

$1.21M+104%

PrecigenPGEN

$109K+116%

ZymeworksZYME

$178.79M+13,486%

ADMA BiologicsADMA

-$10.13M-42.1%

Other financials

Income statement

See full

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

See full

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Total assets$1.3B-2.8%

Cash flow

See full

Operating cash flow-$33.5M-190%

CapEx$3.8M-64.0%

Free cash flow-$37.4M-68.3%

Valuation

See full

Market cap$1.72B+59.2%

Enterprise value$1.76B+100.0%

P/S21.7×-25.0×

Profitability

See full

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

See full

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbCellera Biologics Inc.'s financing cash flow?: AbCellera Biologics Inc. (ABCL) reported financing cash flow of $7.19M in Q1 2026.
How has AbCellera Biologics Inc.'s financing cash flow changed year-over-year?: AbCellera Biologics Inc.'s financing cash flow increased by 20.5% year-over-year, from $5.97M to $7.19M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.